This Insulet Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.

• HC Wainwright & Co. analyst Matthew Keller initiated coverage on Seres Therapeutics Inc (NASDAQ:MCRB) with a Buy rating and announced a price target of $12. Seres Therapeutics shares closed at $6.60 on Monday. See how other analysts view this stock.
• HC Wainwright & Co. analyst Amit Dayal initiated coverage on XCF Global Inc (NASDAQ:SAFX) with a Buy rating and announced a price target of $1. XCF Global shares closed at $0.49 on Monday. See how other analysts view this stock.
• Deutsche Bank analyst Kieran Ryan initiated coverage on DexCom Inc (NASDAQ:DXCM) with a Buy rating and announced a price target of $86. DexCom shares closed at $69.07 on Monday. See how other analysts view this stock.
• Deutsche Bank analyst Kieran Ryan initiated coverage on Insulet Corporation (NASDAQ:PODD) with a Buy rating and announced a price target of $190. Insulet shares closed at $138.97 on Monday. See how other analysts view this stock.
• Deutsche Bank analyst Kieran Ryan initiated coverage on Tandem Diabetes Care, Inc. (NASDAQ:TNDM) with a Hold rating and announced a price target of $15.5. Tandem Diabetes Care shares closed at $14.34 on Monday. See how other analysts view this stock.

Considering buying MCRB stock? Here’s what analysts think:

Photo via Shutterstock